Differential induction of cytokines by human neonatal, adult, and elderly monocyte/macrophages infected with dengue virus

Viral Immunology

Volumn 27, Issue 4, 2014, Pages 151-159

  Valero, Nereida ^a   Mosquera, Jesús ^a   Levy, Alegria ^b   Añez, Germán ^a,d   Marcucci, Rafael ^b   Alvarez Mon, Melchor ^c  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b UNIVERSIDAD DEL ZULIA   (Venezuela)

^c HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADAPTIVE IMMUNITY; ADULT; AGED; ARTICLE; CELL CULTURE; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DENDRITIC CELL; DENGUE; DENGUE VIRUS; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; MONOCYTE CULTURE; MONONUCLEAR CELL; NEWBORN; NONHUMAN; PROTEIN INDUCTION; VIRUS ENTRY; VIRUS TITRATION; VIRUS TYPING; YOUNG ADULT; AGE; ANIMAL; BIOSYNTHESIS; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; VIROLOGY;

ADULT; AGE FACTORS; AGED; ANIMALS; CELLS, CULTURED; CYTOKINES; DENGUE VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT, NEWBORN; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES;

EID: 84900535373     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2013.0123     Document Type: Article

References (36)

1. Anderson R, Wang S, Osiowy C, and Issekutz AC. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol 1997; 71: 4226-4232.
2. Atrasheuskaya A, Petzelbauer P, Fredeking TM, and Ignatyev G. Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection. FEMS Immunol Med Microbiol 2003; 35: 33-42.
3. Bergold GH, and Mazzali R: Plaque formation by arbovirus. J Gen Virol 1968; 2: 273-284.
4. Butthep P, Chunhakan S, Yoksan S, Tangnararatchakit K, and Chuansumrit A. Alteration of cytokines and chemokines during febrile episodes associated with endothelial cell damage and plasma leakage in dengue hemorrhagic fever. Pediatr Infect Dis J 2012; 31: e232-238.
5. Chang DM, and Shaio MF. Production of interleukin-1 (IL- 1) and IL-1 inhibitor by human monocyte exposed to dengue virus. J Infect Dis 1994; 170: 811-817.
6. Choudhry SP, Gupta RK, and Kishan J. Dengue shock syndrome in new born-a case series. Indian Pediatr 2004; 41: 397-399.
7. Ciucci A, Gabriele I, Percario ZA, Affabris E, Colizzi V, and Mancino G. HMGB1 and cord blood: its role as immunoadjuvant factor in innate immunity. PLoS One 2011; 6: e23766.
8. Dasari P, Zola H, and Nicholson IC. Expression of Toll-like receptors by neonatal leukocytes. Pediatr Allergy Immunol 2011; 22: 221-228.
9. Della Bella S, Bierti L, Presicce P, et al. Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin Immunol 2007; 122: 220-228.
10. Djamiatun K, Ferwerda B, Netea MG, van der Ven AJ, Dolmans M, and Faradz SM. Toll-like receptor 4 polymorphisms in dengue virus-infected children. Am J Trop Med Hyg 2011; 85: 352-354.
11. Espina LM, Valero NJ, Hernández JM, and Mosquera JA. Increased apoptosis and expression of tumor necrosis factor-alpha caused by infection of cultured human monocytes with dengue virus. Am J Trop Med Hyg 2003; 68: 48-53.
12. García-Rivera EJ, and Rigau-Pérez JG. Dengue severity in the elderly in Puerto Rico. Rev Panam Salud Publica 2003; 13: 362-368.
13. Gille C, Dreschers S, Leiber A, et al. The CD95/CD95L pathway is involved in phagocytosis-induced cell death of monocytes and may account for sustained inflammation in neonates. Pediatr Res 2013; 73: 402-408.
14. Green A, Beatty PR, Hadjilaou A, and Harris E. Innate immunity to dengue virus infection and subversion of antiviral responses. J Mol Biol 2014; 426: 1148-1160.
15. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998; 11: 480-496.
16. Huang YH, Lei HY, Liu HS, et al. Tissue plasminogen activator induced by dengue virus infection of human endothelial cells. J Med Virol 2003; 70: 610-616.
17. Hottz ED, Lopes JF, Freitas C, et al. Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood 2013; 122: 3405-3414.
18. Kollmann TR, Crabtree J, Rein-Weston A, et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol 2009; 183: 7150-7160.
19. Kuno G, and Bailey RE. Cytokine responses to dengue infection among Puerto Rican patients. Mem Inst Oswaldo Cruz 1994; 89: 179-182.
20. Kurane I. Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comp Immunol Microbiol Infect Dis 2007; 30: 329-340.
21. Lee CC, Hsu HC, Chang CM, Hong MY, and Ko WC. Atypical presentations of dengue disease in the elderly visiting the ED. Am J Emerg Med 2013; 31: 783-787.
22. Levy A, Valero N, Espina LM, Añez G, Arias J, and Mosquera J. Increment of interleukin 6, tumour necrosis factor alpha, nitric oxide, C-reactive protein and apoptosis in dengue. Trans R Soc Trop Med Hyg 2010; 104: 16-23.
23. Martino D, Holt P, and Prescott S. A novel role for interleukin- 1 receptor signaling in the developmental regulation of immune responses to endotoxin. Pediatr Allergy Immunol 2012; 23: 567-572.
24. Ong SP, Lee LM, Leong YFI, Ng ML, and Chu JJH. Dengue virus infection mediates HMGB1 release from monocytes involving PCAF acetylase complex and induces vascular leakage in endothelial cells. PLoS One 2012; 7: e41932.
25. Peoples JD, Cheung S, Nesin M, et al. Neonatal cord blood subsets and cytokine response to bacterial antigens. Am J Perinatol 2009; 26: 647-657.
26. Perera-Lecoin M, Meertens L, Carnec X, and Amara A. Flavivirus entry receptors: an update. Viruses 2014; 6: 69-88.
27. Pillay V, Savage N, and Laburn H. Interleukin-1 receptor antagonist in newborn babies and pregnant women. Pflugers Arch 1993; 424: 549-551.
28. Pillay V, Savage N, and Laburn H. Circulating cytokine concentrations and cytokine production by monocytes from newborn babies and adults. Pflugers Arch 1994; 428: 197-201.
29. Puzik A, Rupp J, Tröger B, Göpel W, Herting E, and Härtel C. Insulin-like growth factor-I regulates the neonatal immune response in infection and maturation by suppression of IFN-c. Cytokine 2012; 60: 369-376.
30. Rich EA, Mincek MA, Armitage KB, et al. Accessory function and properties of monocytes from healthy elderly humans for T lymphocyte responses to mitogen and antigen. Gerontology 1993; 39: 93-108.
31. Shaio MF, Cheng SN, Yuh YS, and Yang KD. Cytotoxic factor released by dengue virus-infected human monocytes. J Med Virol 1995; 46: 216-223.
32. Shaw AC, Joshi S, Greenwood H, Panda A, and Lord JM. Aging of the innate immune system. Curr Opin Immunol 2010; 22: 507-513.
33. Suharti C, van Gorp EC, Setiati TE, et al. The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome. Thromb Headmost 2002; 87: 42-46.
34. van Duin D, and Shaw AC. Toll-like receptors in older adults. J Am Geriatr Soc 2007; 55: 1438-1444.
35. Valero N, Espina LM, Añez G, Torres E, and Mosquera JA. Short report: increased level of serum nitric oxide in patients with dengue. Am J Trop Med Hyg 2002; 66: 762-764.
36. Walk J, Westerlaken GH, van Uden NO, Belderbos ME, Meyaard L, and Bont LJ. Inhibitory receptor expression on neonatal immune cells. Clin Exp Immunol 2012; 169: 164-171.